Earlier this month we launched our new website as part of the exciting evolution of the Arrotek brand. That evolution includes enhancing our design service offering for customers and bringing our brands Needletech and Concert Medical under the Arrotek brand name, reflecting the company’s expanding global footprint.
The new website has a modern design that looks great on all devices, with detailed information on our design, manufacturing, and regulatory solutions. You can watch our latest videos, use our Medical Device Design Calculator to get an estimate for your product development project, or get a quote for a new guidewire solution or specialty medical needle. Our popular Knowledge Hub section also features prominently, and you can find out more about the Arrotek brand and our vision for the future.
Commenting on the launch of the new website Mark Pugh who is CEO of Theragenics, Arrotek’s parent company, and co-founder of Arrotek said: “The medical device industry is rapidly changing, especially in our field of minimally invasive medical devices. It is therefore essential that we continuously evolve and improve our offering to meet the demands of our customers.
“Innovation is at the core of who we are at Arrotek, and we are excited about the future and helping our customers push the boundaries of medical device innovation. We hope you find the information on our website informative as you move your project forward.”
New Signage in Our US Facility
As well as launching our new website, we have also installed new Arrotek signage at our US facility in North Attleboro, Massachusetts.
The installation of the new signage is part of our transition to trading under the Arrotek brand name across all markets, including the US and EU. This is further enhanced with our new website that brings together our core areas of expertise:
- Advanced catheter technologies
- Needles, cannulas, and stylets
- Guidewires
Our focus remains on developing cutting-edge minimally invasive medical devices for customers that range from innovative startups to the largest life sciences sector companies in the world.
The Cutting Edge of Product Development
Ger O’Carroll, co-founder and Managing Director at Arrotek, said: “The medical device products and components that we design transform patient treatments for a range of medical conditions. It’s an exciting time for our industry, especially at the cutting edge of product development.
“Offering best-in-class solutions with the capabilities and available capacity that our customers need has always been a key focus for us at Arrotek. These priorities continue to be a focus as our operations and customer base expand throughout the US, EU, and beyond.
“The transition to bring our US and EU operations under one brand name – Arrotek – has been and continues to be a success. I would like to take this opportunity to thank each member of the Arrotek team for their help, support, and input throughout the process.
“We also have other exciting developments to announce in the very near future – more details on those developments will be announced soon.
“As a company with our expanded design service offering and extensive engineering and manufacturing capabilities, we are well positioned to deliver for our customers in 2024 and beyond, as well as achieving our ambitious growth targets. I would like to thank all our customers for their continued support. We are proud to have the opportunity to work with you, and we look forward to continuing this work in the future.”
Core Expertise at Arrotek
Deirdre Caheny from the Sales & Marketing Team at Arrotek said: “Our aim with the development of our new website was to bring together the core expertise of the company under the Arrotek brand name. We also wanted the website to reflect our values as a company, including our innovative, customer-focused, boundary-pushing approach to medical device design and development projects.
“I encourage you to have a look at the website and please get in touch if you have any questions or would like to discuss your medical design or manufacturing requirements.”
